Liliane Chamas
Directeur/Membre du Conseil chez Credo Therapies Ltd.
Postes actifs de Liliane Chamas
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Oxford Science Enterprises PLC
 Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom. | Private Equity Investor | 01/12/2019 | - |
Amber Therapeutics Ltd.
 Amber Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Amber Therapeutics Ltd. is a British company that develops intelligent bioelectrical therapies that can adapt, respond and learn from each person's individual physiology. The company is based in London, UK. and has subsidiaries in United Kingdom. The company was founded in 2020 by Aidan Harold Winston Crawley. Aidan Harold Winston Crawley has been the CEO since 2020. | Directeur/Membre du Conseil | 18/06/2021 | - |
Credo Therapies Ltd.
 Credo Therapies Ltd. Financial ConglomeratesFinance Credo Therapies Ltd. is a British dormant company that was founded in 2022. | Directeur/Membre du Conseil | 05/12/2022 | - |
Historique de carrière de Liliane Chamas
Formation de Liliane Chamas
| Concordia University | Undergraduate Degree |
Statistiques
Internationale
| Royaume-Uni | 4 |
| Canada | 2 |
Opérationnelle
| Director/Board Member | 2 |
| Private Equity Investor | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Finance | 3 |
| Consumer Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Oxford Science Enterprises PLC
Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom. | Finance |
Amber Therapeutics Ltd.
Amber Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Amber Therapeutics Ltd. is a British company that develops intelligent bioelectrical therapies that can adapt, respond and learn from each person's individual physiology. The company is based in London, UK. and has subsidiaries in United Kingdom. The company was founded in 2020 by Aidan Harold Winston Crawley. Aidan Harold Winston Crawley has been the CEO since 2020. | Health Technology |
Credo Therapies Ltd.
Credo Therapies Ltd. Financial ConglomeratesFinance Credo Therapies Ltd. is a British dormant company that was founded in 2022. | Finance |
- Bourse
- Insiders
- Liliane Chamas
- Expérience
